Why the study?
Do calcium antagonists improve cardiac hypertrophy and mortality compared to vasodilators in hypertensive rats?
Population
Rats with various forms of hypertension
Comparison
Calcium antagonists of the dihydropyridine type vs Vasodilators (hydralazine, minoxidil)
Design
Preclinical
Authors
Loading...
Distinguishes calcium antagonists from vasodilators on hypertrophy in rats; leaves open relevance to human hypertension management.
Do calcium antagonists improve cardiac hypertrophy and mortality compared to vasodilators in hypertensive rats?
In hypertensive rat models, calcium antagonists offer advantages over direct vasodilators by reducing cardiac hypertrophy and improving survival, potentially due to improved renal hemodynamics.
Kazda et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: